Evercore Inc. (EVR)
Price:
337.39 USD
( - -7.28 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Circle Internet Group
VALUE SCORE:
9
2nd position
Morgan Stanley
VALUE SCORE:
9
The best
Raymond James Financial, Inc.
VALUE SCORE:
10
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Evercore Inc., together with its subsidiaries, operates as an independent investment banking advisory firm in the United States, Europe, Latin America, and internationally. It operates through two segments, Investment Banking and Investment Management. The Investment Banking segment offers strategic advisory services, such as mergers and acquisitions, strategic, defense, and shareholder advisory, special committee assignments, and transaction structuring; Capital Markets Advisory, including equity capital markets, restructuring, debt advisory, private placement advisory, market risk management and hedging, private capital advisory, and private funds; and research, sales, and trading professionals services on a content-led platform to its institutional investor clients. The Investment Management segment provides wealth management services to high-net-worth individuals, foundations, and endowments; and manages financial assets for institutional investors. The company was formerly known as Evercore Partners Inc. and changed its name to Evercore Inc. in August 2017. Evercore Inc. was founded in 1995 and is headquartered in New York, New York.
NEWS
Here's Why Evercore (EVR) is a Strong Growth Stock
zacks.com
2025-12-10 10:46:17Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Evercore Inc. (EVR) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript
seekingalpha.com
2025-12-09 11:27:07Evercore Inc. (EVR) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript
Evercore Receives License and Opens Riyadh Office, as Firm Continues to Build in the Middle East
businesswire.com
2025-12-09 05:00:00LONDON--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that it has received its Arranging License from the Capital Markets Authority in the Kingdom of Saudi Arabia and is opening an office in Riyadh to provide independent advice to clients in the Kingdom of Saudi Arabia. The office will be led by Mohammed Aldekmary, who will be based in Riyadh, Kingdom of Saudi Arabia, as CEO of Saudi Arabia and Head of Arranging. Mr. Aldekmary joined the firm in May 2025, spending time in Evercore's Dub.
Ashish Varshneya Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group
businesswire.com
2025-12-04 08:00:00NEW YORK--(BUSINESS WIRE)--Evercore announced today that Ashish Varshneya has joined the firm as a senior managing director in the healthcare investment banking group, focused on healthcare technology. He will be based in New York. “We are thrilled to welcome Ashish to Evercore,” said Naveen Nataraj, co-head of U.S. investment banking. “His deep expertise in healthcare technology will further strengthen our healthcare advisory capabilities in this important sector.” Mr. Varshneya said, “I am de.
Evercore Stock Soars Nearly 38% in 6 Months: Is There More Room to Run?
zacks.com
2025-12-01 15:11:05After EVR's 37.9% six-month surge, can its strong investment banking momentum and solid liquidity keep powering the stock higher? Let us discuss.
Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration
globenewswire.com
2025-12-01 09:00:00Management to Participate in 8th Annual Evercore Annual Healthcare Conference Management to Participate in 8th Annual Evercore Annual Healthcare Conference
ProQR to Participate in 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-12-01 08:00:00LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer™ RNA editing technology platform, today announced that the Company will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025 at 8:20am ET.
Charles River Laboratories to Present at Evercore Healthcare Conference
businesswire.com
2025-12-01 08:00:00WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Evercore Healthcare Conference.
Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-12-01 07:00:00NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. ET.
Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-12-01 07:00:00BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will be participating in a fireside chat at the 8th Annual Evercore Healthcare Conference, being held December 2-4, 2025, in Coral Gables, FL.
ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-12-01 07:00:00Cambridge, Massachusetts, Dec. 01, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease (AD) and other neurodegenerative disorders, today announced that Neil Warma, Chief Executive Officer of ProMIS Neurosciences, will be participating in a fireside chat and investor one-on-one meetings at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2nd, 2025. The fireside chat will be held at 3:25pm Eastern Time and a live webcast of the presentation may be accessed by visiting the Events page of the Company's website at www.promisneurosciences.com.
Why Is Evercore (EVR) Up 8.8% Since Last Earnings Report?
zacks.com
2025-11-28 12:31:57Evercore (EVR) reported earnings 30 days ago. What's next for the stock?
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-11-28 07:30:00NEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, will participate in the 8th Annual Evercore Healthcare Conference, which is taking place from December 2 - 4, 2025.
Evercore ISI's Mark Mahaney on Alphabet: ‘The fundamentals look great'
youtube.com
2025-11-26 10:57:44Mark Mahaney, head of internet research at Evercore ISI, joins CNBC's ‘Squawk on the Street' to discuss Alphabet as the tech giant's stock surges to all-time highs, the ongoing AI race, and more.
Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-11-26 08:00:00PITTSBURGH, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the 8th Annual Evercore Healthcare Conference on December 3, 2025, in Miami. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 10:00 am ET and host investor meetings throughout the day.
Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference
businesswire.com
2025-11-26 06:45:00RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference.
Here's Why Evercore (EVR) is a Strong Growth Stock
zacks.com
2025-12-10 10:46:17Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Evercore Inc. (EVR) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript
seekingalpha.com
2025-12-09 11:27:07Evercore Inc. (EVR) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript
Evercore Receives License and Opens Riyadh Office, as Firm Continues to Build in the Middle East
businesswire.com
2025-12-09 05:00:00LONDON--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that it has received its Arranging License from the Capital Markets Authority in the Kingdom of Saudi Arabia and is opening an office in Riyadh to provide independent advice to clients in the Kingdom of Saudi Arabia. The office will be led by Mohammed Aldekmary, who will be based in Riyadh, Kingdom of Saudi Arabia, as CEO of Saudi Arabia and Head of Arranging. Mr. Aldekmary joined the firm in May 2025, spending time in Evercore's Dub.
Ashish Varshneya Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group
businesswire.com
2025-12-04 08:00:00NEW YORK--(BUSINESS WIRE)--Evercore announced today that Ashish Varshneya has joined the firm as a senior managing director in the healthcare investment banking group, focused on healthcare technology. He will be based in New York. “We are thrilled to welcome Ashish to Evercore,” said Naveen Nataraj, co-head of U.S. investment banking. “His deep expertise in healthcare technology will further strengthen our healthcare advisory capabilities in this important sector.” Mr. Varshneya said, “I am de.
Evercore Stock Soars Nearly 38% in 6 Months: Is There More Room to Run?
zacks.com
2025-12-01 15:11:05After EVR's 37.9% six-month surge, can its strong investment banking momentum and solid liquidity keep powering the stock higher? Let us discuss.
Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration
globenewswire.com
2025-12-01 09:00:00Management to Participate in 8th Annual Evercore Annual Healthcare Conference Management to Participate in 8th Annual Evercore Annual Healthcare Conference
ProQR to Participate in 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-12-01 08:00:00LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer™ RNA editing technology platform, today announced that the Company will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025 at 8:20am ET.
Charles River Laboratories to Present at Evercore Healthcare Conference
businesswire.com
2025-12-01 08:00:00WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Evercore Healthcare Conference.
Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-12-01 07:00:00NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. ET.
Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-12-01 07:00:00BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will be participating in a fireside chat at the 8th Annual Evercore Healthcare Conference, being held December 2-4, 2025, in Coral Gables, FL.
ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-12-01 07:00:00Cambridge, Massachusetts, Dec. 01, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease (AD) and other neurodegenerative disorders, today announced that Neil Warma, Chief Executive Officer of ProMIS Neurosciences, will be participating in a fireside chat and investor one-on-one meetings at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2nd, 2025. The fireside chat will be held at 3:25pm Eastern Time and a live webcast of the presentation may be accessed by visiting the Events page of the Company's website at www.promisneurosciences.com.
Why Is Evercore (EVR) Up 8.8% Since Last Earnings Report?
zacks.com
2025-11-28 12:31:57Evercore (EVR) reported earnings 30 days ago. What's next for the stock?
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-11-28 07:30:00NEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, will participate in the 8th Annual Evercore Healthcare Conference, which is taking place from December 2 - 4, 2025.
Evercore ISI's Mark Mahaney on Alphabet: ‘The fundamentals look great'
youtube.com
2025-11-26 10:57:44Mark Mahaney, head of internet research at Evercore ISI, joins CNBC's ‘Squawk on the Street' to discuss Alphabet as the tech giant's stock surges to all-time highs, the ongoing AI race, and more.
Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference
globenewswire.com
2025-11-26 08:00:00PITTSBURGH, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the 8th Annual Evercore Healthcare Conference on December 3, 2025, in Miami. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 10:00 am ET and host investor meetings throughout the day.
Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference
businesswire.com
2025-11-26 06:45:00RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference.